Stock comparison
LeMaitre Vascular
McKesson
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
MCK
McKesson
Market cap
$91.42B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | MCK | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 57C | LMAT |
| Benjamin Graham | 81A | 28F | LMAT |
| Philip Fisher | 73B | 43D | LMAT |
| Peter Lynch | 59C | 39D | LMAT |
| Joel Greenblatt | 48D | 46D | LMAT |
| Charlie Munger | 60C | 36D | LMAT |
| Terry Smith | 61C | 49D | LMAT |
Side-by-side metrics
| Metric | LMAT | MCK |
|---|---|---|
| Market cap | $2.32B | $91.42B |
| P/E (TTM) | 37.1x | 19.5x |
| EV/EBIT | 36.6x | 14.9x |
| ROIC (TTM) | 9.43% | 31.07% |
| Gross margin | 72.39% | 3.61% |
| Net margin | 24.35% | 1.18% |
| Revenue CAGR 5y | 12.75% | 11.19% |
| EPS CAGR 5y | 19.04% | 51.54% |
| Debt / Equity | 0.5x | - |
| Dividend yield | 0.84% | 0.42% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Net margin24.35%vs 1.18%+95%
- Gross margin72.39%vs 3.61%+95%
- Dividend yield0.84%vs 0.42%+50%
- Revenue CAGR 5y12.75%vs 11.19%+12%
MCK leads on
- Debt / Equity-vs 0.5x+112%
- Market cap$91.42Bvs $2.32B+97%
- ROIC (TTM)31.07%vs 9.43%+70%
- EPS CAGR 5y51.54%vs 19.04%+63%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.